Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Genetic Diagnosis of Inherited Bleeding Disorders in 1250 Probands From India: A Single Centre Experience

Giridhara R Jayandharan, Ph.D, Govindanattar Sankari Devi, S RajKumar, Everette Nelson, Ramachandran V Shaji, Neeraj Arora, P Shenbagaapriya, Sukesh C Nair, MD, Auro Viswabandya, MD, Biju George, MD, Vikram Mathews, Alok Srivastava, MD

Blood (2012) 120 (21): 1127.

https://doi.org/10.1182/blood.V120.21.1127.1127

Published: 2012

Journal Articles

Increased Cytotoxic T-Cell Infiltrates in the Bone Marrow Is an Independent Adverse Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma.

Grzegorz S. Nowakowski, MD, Chin-Yang Li, MD, David Dingli, MD, PhD, Shaji Kumar, MD, Morie A. Gertz, MD, Martha Q. Lacy, MD, John A. Last, MD, Angela Dispenzieri, MD, Philip R. Greipp, MD, Steven Zeldenrust, MD, PhD, Francis Buadi, MD, Suzanne Hayman, MD, Robert A. Kyle, MD, Vincent S. Rajkumar, MD

Blood (2007) 110 (11): 1492.

https://doi.org/10.1182/blood.V110.11.1492.1492

Published: 2007

Journal Articles

Thalidomide Based Induction Chemotherapy Prior to Stem Cell Transplantation in Myeloma Is Associated with Decreased Response to Retreatment with Thalidomide at First Relapse Post Transplant.

Lijo Simpson, MBBS, Morie Gertz, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis Buadi, MD, Vincent S. Rajkumar, MBBS, Shaji Kumar

Blood (2007) 110 (11): 3607.

https://doi.org/10.1182/blood.V110.11.3607.3607

Published: 2007

Journal Articles

SNP Associations with Event Free Survival in Myeloma from Two Phase III Clinical Trials Using the Bank On A Cure Chip.

Brian G. Van Ness, PhD, John C. Crowley, Ph.D., Christine Ramos, B.S., Suzanne M. Grindle, Ph.D., Antje Hoering, Ph.D., Jeff Haessler, M.S., Susanna Jacobus, M.S., Brian G. Durie, MD, Michael Katz, Ph.D., Vincent S. Rajkumar, MD, Bart Barlogie, MD, David C. Johnson, Ph.D., Gareth J. Morgan, MD

Blood (2006) 108 (11): 131.

https://doi.org/10.1182/blood.V108.11.131.131

Published: 2006

Journal Articles

The Genetic Contribution to the Aetiology of Thalidomide Associated VTE.

Gareth J. Morgan, MD, PhD, David C. Johnson, BSc, John Crowley, PhD, John Shaughnessy, Jr., PhD, Pieter Sonneveld, MD, Brian Durie, MD, Christine Ramos, PhD, Brian G. Van Ness, PhD, Bart Barlogie, MD, Antje Hoering, PhD, Jeff Haessler, PhD, Dalsu Baris, MD, PhD, Michael Katz, BS, Vincent S. Rajkumar, MD, H. Goldschmidt, MD

Blood (2006) 108 (11): 246.

https://doi.org/10.1182/blood.V108.11.246.246

Published: 2006

Journal Articles

Immunoglobulin Free Light Chains at Diagnosis: Predictors of Progression and Survival in Solitary Plasmacytoma of Bone.

David Dingli, MD, PhD, Robert A. Kyle, MD, Vincent S. Rajkumar, MD, Grzegorz S. Nowakowski, MD, Dirk R. Larson, MS, John P. Bida, MA, Morie A. Gertz, MD, Angela Dispenzieri, MD, L. J. Melton, III, MD, Terry M. Therneau, PhD, Jerry A. Katzmann, PhD

Blood (2005) 106 (11): 5080.

https://doi.org/10.1182/blood.V106.11.5080.5080

Published: 2005

Journal Articles

Flow Cytometric Detection of Circulating Myeloma Cells Pretransplant in Patients with Multiple Myeloma: A Simple Risk Stratification System.

David Dingli, MD, PhD, Grzegorz S. Nowakowski, MD, Angela Dispenzieri, MD, Martha Q. Lacy, MD, Suzanne R. Hayman, MD, Vincent S. Rajkumar, MD, Philip R. Greipp, MD, Mark R. Litzow, MD, Dennis A. Gastineau, MD, Thomas E. Witzig, MD, Morie A. Gertz, MD

Blood (2005) 106 (11): 1164.

https://doi.org/10.1182/blood.V106.11.1164.1164

Published: 2005

NARROW

Genetic Diagnosis of Inherited Bleeding Disorders in 1250 Probands From India: A Single Centre Experience

Increased Cytotoxic T-Cell Infiltrates in the Bone Marrow Is an Independent Adverse Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma.

Thalidomide Based Induction Chemotherapy Prior to Stem Cell Transplantation in Myeloma Is Associated with Decreased Response to Retreatment with Thalidomide at First Relapse Post Transplant.

SNP Associations with Event Free Survival in Myeloma from Two Phase III Clinical Trials Using the Bank On A Cure Chip.

The Genetic Contribution to the Aetiology of Thalidomide Associated VTE.

Immunoglobulin Free Light Chains at Diagnosis: Predictors of Progression and Survival in Solitary Plasmacytoma of Bone.

Flow Cytometric Detection of Circulating Myeloma Cells Pretransplant in Patients with Multiple Myeloma: A Simple Risk Stratification System.

Email alerts

ASH Publications

American Society of Hematology

Genetic Diagnosis of Inherited Bleeding Disorders in 1250 Probands From India: A Single Centre Experience

Increased Cytotoxic T-Cell Infiltrates in the Bone Marrow Is an Independent Adverse Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma.

Thalidomide Based Induction Chemotherapy Prior to Stem Cell Transplantation in Myeloma Is Associated with Decreased Response to Retreatment with Thalidomide at First Relapse Post Transplant.

SNP Associations with Event Free Survival in Myeloma from Two Phase III Clinical Trials Using the Bank On A Cure Chip.

The Genetic Contribution to the Aetiology of Thalidomide Associated VTE.

Immunoglobulin Free Light Chains at Diagnosis: Predictors of Progression and Survival in Solitary Plasmacytoma of Bone.

Flow Cytometric Detection of Circulating Myeloma Cells Pretransplant in Patients with Multiple Myeloma: A Simple Risk Stratification System.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only